A
Algama
A next-generation daily food product company that harnesses the unique potential of microalgae with a tasty spoonful of joy: good for people and sustainable
About Algama
Founded in 2013 by Alvyn Severien, Gaetan Gohin, and Mathieu Goncalves, Algama is a food-technology firm focused on developing ingredients from microalgae as alternatives to animal-based products. The founders, childhood friends with backgrounds in finance, were drawn together by a shared personal interest in microalgae's nutritional benefits, like spirulina, which they took as dietary supplements. This personal journey into the potential of algae inspired them to leave their careers and establish a company with the objective of integrating microalgae into everyday foods.
Read full description
Algama operates primarily on a business-to-business model, providing its expertise in co-development and formulation to food manufacturers and industrial clients. The company generates revenue by supplying these partners with its algae-based ingredients. Its target market includes industrial and artisanal players in the bakery, pastry, and confectionery industries who are seeking to replace eggs due to price volatility, supply chain disruptions, and shifting consumer preferences. Key corporate partners and investors include major food industry groups like Thai Union and Grupo Bimbo, as well as impact investors such as Blue Horizon and Horizons Ventures.
The company's flagship product line is TAMALGA®, a range of powdered egg substitutes derived from microalgae. This product is designed to replicate the key functionalities of eggs in baking—such as binding, emulsifying, foaming, and gelling—by combining microalgae with other plant-based ingredients. TAMALGA® offers a solution to the challenges of the egg market, including rising costs and the impact of events like avian flu, while also providing a cost-effective and environmentally sustainable alternative. Beyond egg substitutes, Algama's research and development has led to the creation of over 200 products, including vegan mayonnaise, dairy-free milk, and seafood alternatives like plant-based salmon and tuna. The company holds a significant intellectual property portfolio, with numerous patents covering its processes and formulations across dozens of countries.
Since its inception, Algama has secured substantial funding to fuel its growth, including a €13 million Series A round in early 2023. This capital is aimed at scaling up production, which includes the establishment of a 10,000 m2 industrial site in Belgium, and expanding its commercial reach. The company maintains operations in France, Belgium, and the United States. Keywords: microalgae ingredients, egg substitute, plant-based alternatives, food technology, B2B ingredients, bakery solutions, sustainable food, vegan seafood, alternative proteins, TAMALGA, Alvyn Severien, food formulation, algae-based protein, plant-based dairy, egg replacement, food science, pastry ingredients, confectionery solutions, vegan mayonnaise, sustainable aquaculture
At a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Malakoff, France
- Employees
- 35
- Open positions
- None listed
- Dealroom signal
- 61.9/100
- Industry
- Wellness Beauty
- Sub-industry
- Innovative Food
- Sector
- Food, Biotechnology, Algae, Superfood, Nutrition, Beverage, Plant-Based, Primary Production, Alternative Protein, Meat Substitute, Sustainable Development Goals
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jan 2023 | $14M | $57M | Thai Union | ↗ |
| GRANT✓Other financing | Oct 2021 | $2.2M | — | European Commission | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Algama is 1.3K monthly website visits, up 261.1% over the last three months. Algama's team declined 18.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Marc Simoncini
Jacques-Antoine Granjon
Xavier Niel
European Innovation Council
European Commission
Series A5 investors entered at this stage
Horizons Ventures
Beyond Impact Vegan Partners
Blue Horizon
VegInvest
Thai Union
Other known investors10 additional known investors
Agoranov
Alwyn Capital
Angelor
Angels for Impact
CPT Capital
Ilias Hicham
Louis Dreyfus Company
Newtree Impact
Plug and Play
Unreasonable Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Algama on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Algama’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







